Sanofi India Limited successfully concluded its 70th Annual General Meeting on April 29, 2026, with all 11 resolutions receiving overwhelming shareholder approval. The meeting, conducted virtually from 3:30 PM to 5:25 PM IST, witnessed significant leadership transitions and strong participation with 85.50% of outstanding shares being voted across all resolutions.

Meeting Overview and Participation

The AGM was attended by 72 members virtually, including 2 promoter representatives and 70 public shareholders. Mr. Sunny Gogiya (ACS 56804, CP 21563), Partner at M/s. SGGS & Associates, served as the scrutinizer and issued the official report on April 29, 2026. The remote e-voting facility was available from April 25, 2026 (9:00 AM IST) to April 28, 2026 (5:00 PM IST).

Leadership Transitions and Board Changes

The AGM marked significant leadership changes with Chairman Aditya Narayan concluding his tenure on April 29, 2026. Mr. Rahul Bhatnagar will assume the position of Chairman effective April 30, 2026. The meeting also saw the completion of Mrs. Usha Thorat's tenure as Independent Director and welcomed new appointments including Ms. Rajani Kesari and Mr. Siraj Chaudhry as Independent Directors.

Financial Resolutions and Dividend Approval

Shareholders approved key financial matters including the adoption of annual audited financial statements for the year ended December 31, 2025. The dividend resolution received exceptional support, confirming the payment of interim dividend of Rs. 75 per equity share and declaring a final dividend of Rs. 48 per equity share, totaling Rs. 123 per share for FY25.

Related Party Transaction Approvals

Two material related party transaction resolutions were approved with promoter groups abstaining from voting as per regulatory requirements. Both transactions with Sanofi-Aventis Singapore Pte. Limited and Sanofi Healthcare India Private Limited received approval rates above 99.82% from non-promoter shareholders.

Regulatory Compliance and Documentation

Company Secretary Haresh Vala (Membership No: A18246) ensured full regulatory compliance by filing the consolidated voting results with BSE and NSE under Regulation 30 of SEBI regulations. The scrutinizer's report was issued on April 29, 2026, confirming that all resolutions were duly passed with requisite majority. The voting results and scrutinizer's report are available on the company's website and NSDL portal, demonstrating strong shareholder confidence in the company's strategic direction and governance processes.

Sanofi India Limited has announced its 70th Annual General Meeting (AGM) scheduled for Wednesday, April 29, 2026 at 3:30 PM IST. The meeting will be conducted through video conferencing and other audio-visual means facility, in compliance with regulatory guidelines.

Regulatory Compliance and Publication

The company has fulfilled its regulatory obligations by publishing newspaper advertisements in Business Standard (English) and Sakal (Marathi) on April 3, 2026. This publication was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as confirmed by Company Secretary Haresh Vala in the official communication to stock exchanges.

Meeting Agenda and Key Business Items

The AGM will address both ordinary and special business matters crucial to the company's operations. The ordinary business includes adoption of audited financial statements for the financial year ended December 31, 2025, dividend matters, and director re-appointments.

Dividend Proposals

The company will seek confirmation of interim dividend payment of ₹75 per equity share and declaration of final dividend of ₹48 per equity share for the financial year ended December 31, 2025.

Director Appointments and Re-appointments

The meeting will address several key leadership changes:

Re-appointments:

• Mr. Vaibhav Karandikar (DIN: 09049375) - retiring by rotation
• Mr. Eric Mansion (DIN: 10654588) - retiring by rotation

New Appointments:

• Ms. Sudipta Chakraborty (DIN: 07166912) as Director and Whole-time Director for three years from March 1, 2026 to February 28, 2029
• Mrs. Rajani Kesari (DIN: 02384170) as Independent Director for five years from April 1, 2026 to March 31, 2031
• Mr. Siraj Azmat Chaudhry (DIN: 00161853) as Independent Director for five years from April 1, 2026 to March 31, 2031

Material Related Party Transactions

The company seeks approval for significant related party transactions expected to exceed materiality thresholds:

These transactions represent 75.38% and 28.85% of the company's annual turnover respectively for the preceding financial year.

Cost Auditor Remuneration

Shareholders will ratify the appointment and remuneration of M/s. Kishore Bhatia & Associates as Cost Auditors for the financial year ending December 31, 2026, with remuneration of ₹4,60,000 plus applicable taxes and out-of-pocket expenses.

Meeting Participation Guidelines

The AGM will accommodate 1,000 members on a first-come, first-served basis through video conferencing. Remote e-voting will be available from Saturday, April 25, 2026 at 9:00 AM to Tuesday, April 28, 2026 at 5:00 PM. The cut-off date for determining voting eligibility is Wednesday, April 22, 2026.

Members can access the complete notice and annual report through the company's website and stock exchange portals. The company has appointed Mr. Gaurav Sainani or Mr. Sunny Gogiya from M/s. SGGS and Associates as scrutinizers for the voting process.